Terumo Corp. Hits Day High with Strong 3.81% Intraday Surge

Terumo Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 3.81% as of February 25, 2026. The stock reached an intraday high of JPY 2,059.50, marking a notable performance against the backdrop of a declining Japan Nikkei 225, which fell by 1.12% on the same day. Over the past week, Terumo Corp. has maintained a positive trajectory with a 3.76% increase, contrasting with the Nikkei's slight decline of 0.2%. However, the company's longer-term performance reveals challenges, with a 23.34% drop over the past year and a staggering 50.32% decrease over the last five years. Despite these hurdles, Terumo Corp. demonstrates a robust ability to manage its debt, evidenced by a strong EBIT to Interest ratio of 36.60. The company has also seen a healthy annual growth rate of 10.50% in net sales. With a market capitalization of JPY 3,260,192 million, Terumo Corp. continues to navigate a competitive landscape while facing consistent underperformance against its benchmark.